cerebral blood volume; near-infrared spectroscopy OVER THE LAST DECADE, near-infrared spectroscopy (NIRS) has found widespread application for the monitoring of tissue hemodynamics and oxygenation (7, 11, 24) . Because the technique allows the continuous and noninvasive measurement of changes in concentration of oxyhemoglobin (⌬HbO 2 ), deoxyhemoglobin (⌬Hb), and changes in the redox state of cytochrome oxidase, its simplest application is as a trend monitor of global tissue oxygenation status. If the ⌬HbO 2 and ⌬Hb signals are summed, this provides a derived measurement of changes in total hemoglobin concentration (⌬[Hb] tot ), which can be used to reflect changes in blood volume.
An important step in the development of NIRS occurred when methods for the measurement of absolute hemodynamic parameters were devised. In 1988, Edwards et al. (6) described the measurement of absolute blood flow by using a small but rapid change in concentration of HbO 2 as an intravascular nearinfrared dye. The technique was first applied to the measurement of neonatal cerebral blood flow and, in a subsequent validation, was shown to correlate with the xenon-clearance method (20) .
By 1990, a method for the measurement of absolute cerebral hemoglobin concentration (CHC) had been described (25) . This method employs a small, but this time slow, change in HbO 2 concentration and, for this reason, is usually referred to as the O 2 method for estimating cerebral blood volume (CBV). To date, independent validation of this method has not been performed, although the technique has been widely used after its initial application in neonatal medicine (15, 22, 26) .
It is, therefore, possible to attempt an internal validation by comparing changes in CBV measured from the continuous ⌬[Hb] tot measurement against the change calculated from two separate absolute concentration measurements (⌬CHC ϭ CHC 2 Ϫ CHC 1 ). One study (2) attempted such a comparison by using CO 2 -induced CBV changes in a small number of newborn infants and reported a significant difference in the values obtained by each method: 0.89 ml · 100 g Ϫ1 · kPa Ϫ1 for the absolute O 2 method vs. 0.22 ml·100 g Ϫ1 ·kPa Ϫ1 for the continuouschange measurement (⌬[Hb] tot ).
The aim of the study reported here was to confirm these observations in a more controlled animal model, and to investigate, from a theoretical basis, the possible reasons for any differences. This paper will describe measurements in which a change in fraction of inspired O 2 (FI O 2 ) was used to measure CBV (by using the O 2 method) and a change in fraction of inspired CO 2 (FI CO 2 ) was used to change CBV.
NIRS MEASUREMENT THEORY
In a nonscattering medium, the attenuation A of light traveling a distance d is simply given by the equation
where each absorber i has a concentration C i and a specific absorption coefficient µ a i . In a scattering medium, such as biological tissue, the scattering acts to increase the path traveled, and, as shown by the diffusion Eq. 1, attenuation is no longer a linear function of the µ a . For small changes in absorption, however, changes in attenuation can be approximated by
which gives
where ␤ is the factor by which the optical pathlength has been increased due to scattering [the so-called It is important to remember that NIRS measures changes in chromophore concentration in micromolar units. Estimates of blood volume are obtained from these measurements by converting the concentration data into the more conventional clinical units of milliliters/100 grams. This conversion requires knowledge of the concentration of red blood cells (the hematocrit). The hematocrit varies with vessel size and is lower in smaller vessels and capillaries. Lammertsma et al. (13) measured the cerebral-to-large vessel hematocrit ratio as 0.69, and Sakai et al. (19) found a value of 0.76. The value measured depends on the distribution of vessel sizes considered. Sakai et al. also found that the hematocrit may change with blood volume. For a 15% increase in blood volume (induced by 5% CO 2 inhalation), the hematocrit dropped by 5%. For these reasons, the present study considers only the measurement of hemoglobin concentration, rather than blood volume.
Experimental Procedure
Five newborn piglets (age Ͻ24 h) were studied. Anesthesia was induced by using 5% isofluorane, mechanical ventilation was established, and the isofluorane level was reduced to 1.5%. Ventilation was maintained at FI O 2 of 40% (balance N 2 ). The optodes from a Hamamatsu NIRO 500 spectrometer were placed on either side of the head at spacings between 3.8 and 4.5 cm (Table 1) . By using pulsed laser diodes at four wavelengths (779, 821, 855 and 908 nm), the spectrometer was used to measure changes in the concentration of cerebral HbO 2 and Hb. For newborn piglets, a differential pathlength factor (4.57) was used to convert the data to micromolar units (R. Springett, personal communication). Sa O 2 and heart rate were measured by using a pulse oximeter (Novametrix 500) via a probe positioned on a skin flap on the right leg. Mean arterial blood pressure was recorded via the umbilical artery, and analog outputs from the oximeter and blood pressure transducer were linked directly to the spectrometer for display and storage alongside the NIRS data. All data were sampled every 2 s.
A computer-controlled gas blender (8) was used to supply a controlled, accurate mixture of O 2 , N 2 , and CO 2 to the time-cycled ventilator (Vickers model 77) with preset pressure. Initially, FI CO 2 was set to 0%, and at least six CHC measurements were made by slowly varying FI O 2 over several minutes. FI CO 2 was then increased to either 2.5 or 5%. Once a new stable baseline had been reached, the CHC measurements were repeated. Arterial blood samples were used to measure arterial PCO 2 throughout the study.
Experimental Results
An example of the NIRS and Sa O 2 data collected during a single CHC measurement in one piglet is shown in Fig. 1 . In this example, Sa O 2 was reduced to ϳ50%. However, only the initial portion of this change (in which Sa O 2 is Ͼ90%) is used for the calculation of CHC. As previously described, CHC is calculated from the gradient of the ⌬[Hb] diff and ⌬Sa O 2 plot shown in Fig. 2 . ⌬[Hb] tot is included on this plot to demonstrate that, for small changes in Sa O 2 , the cerebral circulation is not disturbed. At least three CHC measurements were made at each of the two levels of Pa CO 2 for each 
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MEASUREMENT OF BLOOD VOLUME CHANGES BY USING NIRS piglet. The summarized results of these measurements are shown in Fig. 3 and detailed in Table 1 . The normocapnic Pa CO 2 levels for each piglet ranged between 3.8 and 6.8 kPa.
The coefficient of variation for the CHC method was 22.8 Ϯ 3.5% (mean Ϯ SD) compared with 2.8 Ϯ 2.8% for the [Hb] tot method. A statistical calculation (assuming a power of 90% at the 95% significance level) was performed on the CHC data to determine the minimum change in CHC which could be detected (min [⌬CHC] 
THEORETICAL MODEL
To investigate this problem theoretically, we used diffusion theory (1, 18) to calculate the expected attenuation of light from known values of absorption and scattering of tissue and blood and also the sourcedetector separation. The tissue was assumed to be a uniform slab of 40-mm thickness, with an optode spacing of 40 mm (similar to that used in the experimental study). Data were calculated by using absorption and scattering properties at four wavelengths, chosen to be similar to those used by the NIRO 500. The values used for the µ a of hemoglobin and water are shown in Table 2 . Data are taken from Matcher et al. (17) for blood and from Matcher et al. (16) for water and then converted to natural log base (ln). The µ a of blood was calculated by assuming a hemoglobin concentration in the blood of 1.68 mM (10.8 g/100 ml) and a mean saturation of 80%. To calculate blood volume, we used a saturation decrease of 3%.
The transport scattering coefficient, µЈ s , is defined as µ s (1 Ϫ g, where g is the anisotropy factor of blood). This was assumed to vary linearly with wavelength and was calculated from the following expression [approxi- Fig. 1 
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An average µ a for tissue was calculated by assuming a fraction of blood vessels (f v ) per unit volume of tissue, using
where µ a b is the µ a of blood, µ a w is the absorption of water, and k is a wavelength-independent constant. For the study, calculations were made by assuming f v ϭ 0.02 for the low blood volume and an increase of 15%, giving the higher blood volume fraction as f v ϭ 0.023. These correspond to CHC values of 33.6 and 38.64 µM, respectively.
Recent papers (10, 14) have shown that, when the blood is confined to vessels, embedded in a highscattering, low-absorbing background, the effective absorption of the tissue will vary inversely with the vessel diameter. To investigate the effect of blood vessel size, we used the expression derived by Liu et al. (14) for the effective µ a
where r is the radius of the vessels, and the tissue absorption µ a ϭ µ a w ϩ k. It has been suggested that, in the neonate, because skull bones are not fused, the head could expand slightly with a blood volume increase, leading to a change in the optode spacing. To investigate the effect of optode movement, the source-detector separation used in the diffusion equation was varied by Ϯ1 mm.
THEORETICAL RESULTS

Optical Pathlength and Background Absorption
Both methods for measuring concentration change rely on knowledge of the differential pathlength factor ␤, because the hemoglobin concentrations calculated are inversely proportional to ␤. Thus, if ␤ changes during the measurement, for whatever reason, the concentration measurement will be affected.
Changing the µ a of the medium will alter ␤ by a small amount. On the basis of diffusion theory, it is possible to calculate that, for typical tissue optical properties of µ a ϭ 0.02/mm and µ s ϭ 1.0/mm, a 15% increase in absorption will lead to a 4% decrease in the pathlength ␤.
The continuous ⌬[Hb] tot is calculated directly from changes in attenuation. Thus, this variation in pathlength will give rise to a 4% error in the measured change in concentration (i.e., a 15% change in concentration would be measured as a 14.4% change).
For the ⌬CHC method, the difference between two absolute concentrations is calculated, and the pathlength change will lead to an error in the absolute concentration (i.e., the second concentration will be 4% too small). If the difference is calculated for an initial concentration of C and an increase of 15% ⌬C ϭ (C · 0.96 · 1.15) Ϫ C ϭ 0.1C (8) In this case, a 10% difference has been measured in instead of the actual 15%. The change in pathlength with increased blood volume is dependent on the absorption properties of the bloodless tissue. If the background absorption of blood tissue is zero, then a 15% increase in blood volume results in a 15% increase in absorption. However, if the background absorption of the tissue is nonzero, then a change in the blood volume will have a lesser effect on the total absorption. Figure 4 shows the theoretical estimate of the measured change in hemoglobin concentration for the two techniques as calculated for different background µ a (for differing values of k in Eq. 6). As expected from the above discussion, for low background absorption, the ⌬CHC method underestimates the real value. As the background absorption increases, the continuous ⌬[Hb] tot method gives smaller values.
Effect of s
As an example of the effect of a change in µ s , Fig. 4 also shows the effect on the blood volume measurements of a 1% drop in µ s simultaneous with an increase in blood volume. Figure 5 shows the effect on the [Hb] tot measurements of restricting the change in volume to blood vessels of different diameters. As blood becomes concentrated in fewer, larger vessels, the observed concentration change, as measured by both the ⌬CHC and ⌬[Hb] tot methods, decreases. Figure 6 shows the effect of a Ϯ1-mm optode movement on the measurement of ⌬[Hb] tot and ⌬CHC for a 
Blood Vessel Diameter
Movement of Optodes
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MEASUREMENT OF BLOOD VOLUME CHANGES BY USING NIRS fixed change in blood volume of 15%. This model predicts that optode movement will have a greater effect on the [Hb] tot than on the CHC signal; i.e., with zero optode movement, ⌬[Hb] tot ϭ 15% and ⌬CHC ϭ 10%; however, in the presence of optode movement of 1 mm, the observed ⌬[Hb] tot ϭ 29%, whereas the CHC signal will still show a change of 10%. These data have been calculated by assuming a movement of the optodes occurring between measurement of volumes but also assuming that the optode positioning is constant during any given CHC measurement.
DISCUSSION
Experimental Results
It can been seen clearly that the variability of the CHC values is far greater than the variability of the ⌬[Hb] tot data. By using the CHC values obtained at the lower CO 2 levels, the sensitivity of the measurement was calculated and was found to be inadequate to accurately resolve the changes in CHC caused by the increase in FI CO 2 . For the data presented, although ⌬[Hb] tot always shows an increase with FI CO 2 , CHC does not show a significant change.
The calculation of CHC in Eq. 4 involves finding the regression between ([HbO 2 ] Ϫ [Hb]) and ⌬fSa O 2 . To avoid changes in blood volume and flow, the changes of ⌬Sa O 2 are usually restricted to Ͻ10%. These changes are measured by using pulse oximeters with typical accuracy of Ϯ2% (21) . Therefore, it is likely that the error on the Sa O 2 reading may be responsible for a large degree of the noise in the CHC measurement. A further problem can be the limited analog-output step size of pulse oximeters, because some output data only in steps of 1%.
The noise in the measurement of [Hb] diff is approximately the same as that for measurement of [Hb] tot . However, in the conversion to an absolute concentration, the former is divided by a small factor (⌬fSa O 2 ) which acts to multiply the noise. This is further compounded by errors in the measurement of Sa O 2 .
Unfortunately, although greater Sa O 2 changes would potentially lead to more accurate estimations of blood volume, a large change in Sa O 2 might also result in physiological effects, such as changes in blood volume or flow, which would invalidate the basis of the measurement. Also, for clinical use of the technique, there are obvious limits on the change in FI O 2 which can be used without compromising the patient's health.
Intersubject variability in DPF has been shown to be on the order of 12-17% (5). However, in these studies, DPF acts purely as an equal scaling factor on both the ⌬CHC and ⌬[Hb] tot data to convert the units from micromoles/centimeter to micromoles and, as such, will not contribute to the discrepancy shown between the two measurements.
Theoretical Results
The effect of background tissue absorption can be understood by considering the fact that, when blood volume increases, the tissue volume sampled by the light decreases. Hence, any attenuation caused by tissue absorption will decrease. This acts to lessen the overall increase in attenuation with blood volume and will thus tend to lead to an underestimate of the hemoglobin concentration change. Increasing the number of wavelengths used would make the fitting to the Hb spectral shape more accurate and thus decrease this error (17) .
The theoretical modeling of changes in µ s demonstrates a significant effect on the measurement of CHC. However, it is difficult to think of physiological circumstances under which such a change in µ s might be observed. It would seem unlikely that the µ s of tissue would change by more than a fraction of a percent under normal physiological circumstances. The overall µ s might vary as the blood volume changes, due to a change in the µ s of blood. Kienle et al. (12) measured 1919 the anisotropy factor of blood g at 820 nm as 0.993 and its µ s as 5.5/mm for a hematocrit of 0.01 (which agrees well with Mie theory calculations for red blood cells). This corresponds to a µ s of 134/mm for a hematocrit of 0.41 and a µЈ s of 0.94/mm. Because the transport µ s of neonatal brain tissue is ϳ1.0/mm (23), the change in µ s due to a small increase in blood volume will be negligible. Changes in scattering caused by the depolarization of neurons both in the normal brain during cortical activation and under pathological conditions of stroke are presently the subject of much investigation (3, 9) . Typically the magnitude of any changes seen under these conditions is very small, particularly compared with changes resulting from a change in µ a ; hence, such changes would also have a negligible effect on the described model.
There is some uncertainty in the value of g for blood, and since it is so close to 1.0, uncertainty in g will lead to large uncertainty in µЈ s . However, because a blood volume increase of 15% is only 0.3% of the total (ϳ2%) volume, the maximal decrease in scattering would be 0.3% if blood were nonscattering. A 1% increase in scattering could be caused only if blood had a µ s 5 times that of the surrounding tissue, which is clearly not the case.
As expected, the modeling of the effect of vessel diameter demonstrates that the measured hemoglobin concentration change decreases as the blood becomes concentrated in fewer, larger vessels. However, because the majority of vessels inside the brain are Ͻ0.2-mm diameter, this is unlikely to have a major overall effect. It is possible, however, that a significant change in blood volume confined to the larger pial arteries and veins on the brain surface could lead to an underestimate of the hemoglobin concentration change.
The effect of optode movement is clearly more significant in the measurement of ⌬[Hb] tot than ⌬CHC. In practice, it is probable that the optodes will be subject to continuous small random movements, which will give rise to greater noise and uncertainty in the measurement. This effect is likely to be larger for the CHC measurement, for the reasons previously stated, because ⌬CHC is derived from a difference of two measurements.
In conclusion, the measurement of absolute hemoglobin concentration has been shown to be inherently more liable to noise than measurements of changes in hemoglobin concentration.
The absolute value of CHC measured with this technique is dependent on the µ a of the tissue surrounding the blood vessels. The ⌬[Hb] tot measurement is less sensitive to the background µ a , but it is affected more by any changes that occur in the µ s of the tissue. Measures which might lead to an improved understanding of the CHC data would be 1) to monitor the optical pathlength during the experiment, 2) to improve the accuracy of the pulse oximetry, and 3) to use more wavelengths to improve fitting to the hemoglobin absorption spectra.
